Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com Related Posts Corporate Presentation September 11, 2025 Two Pools Project expands with new tenement applications September 11, 2025 Hydrogen Stocks: 9 Biggest Companies in 2025 September 11, 2025